Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease

BACKGROUND: It is well-established that influenza vaccination reduces adverse cardiovascular outcomes in patients with cardiovascular diseases (CVD), however, the vaccine coverage rate in most countries remains low. The concern about the local adverse effects of intramuscular injection, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Phrommintikul, Arintaya, Wongcharoen, Wanwarang, Kuanprasert, Srun, Prasertwitayakij, Narawudt, Kanjanavanit, Rungsrit, Gunaparn, Siriluck, Sukonthasarn, Apichard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076453/
https://www.ncbi.nlm.nih.gov/pubmed/25009563
http://dx.doi.org/10.3969/j.issn.1671-5411.2014.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076453/
https://www.ncbi.nlm.nih.gov/pubmed/25009563
http://dx.doi.org/10.3969/j.issn.1671-5411.2014.02.007

Ejemplares similares